Markets on Polymarket are currently pricing a 28% probability that the United States will record at least 10,000 measles cases in 2026. The outcome remains uncertain, reflecting both recent trends and ongoing public health efforts.
Measles, a highly contagious viral disease, has seen a resurgence in recent years, partly due to declining vaccination rates in some communities. The U.S. Centers for Disease Control and Prevention (CDC) reported over 1,200 cases in 2019, the highest in decades, driven by outbreaks in under-vaccinated populations. However, robust vaccination campaigns and public health measures have since kept annual cases well below that figure.
The market's split outlook reflects uncertainty about whether vaccination rates will remain stable or decline further, potentially influenced by vaccine hesitancy or policy changes. The resolution of this market will depend on official CDC data for 2026, with the market set to close on December 31, 2026.
PreNews notes that while the market's liquidity is moderate, the probability offers a reasonable signal of current sentiment.